Robyn Coward is the life sciences director at QAD. With 21 years of experience in product commercialization, she has spent the last 11 years focused on the global life sciences markets, particularly in the imaging, laboratory diagnostics, and healthcare IT segments. In her role, Coward monitors and reports on the trends affecting QAD’s life sciences customers. She is a member of several industry organizations including the Medical Device Contract Manufacturing Trends Group, Life Sciences Technology and Compliance Group, the International Society of Pharmaceutical Engineering (ISPE), and the Healthcare Businesswomen’s Association. Coward also participates in various Biocom Institute activities, and enjoys residing in the San Francisco Bay area, one of the world’s hubs for biotechnology, pharmaceutical, and medical device development and manufacturing, where she can see exciting and emerging healthcare innovations before they hit the market.